NTLA
Intellia Therapeutics, IncstockNASDAQ
Market OpenNov 19, 2026 3:14:28 PM EST
9.13USD-6.551%(-0.64)4,835,920
Pre-marketNov 19, 2026 9:29:30 AM EST
9.91USD+1.433%(+0.14)
NTLA Financials
In Q3 FY 2026 (ended ), Intellia Therapeutics, Inc (NTLA) reported revenue of $7.16M, net income of −$127.49M, operating cash flow of −$85.43M, and assets of $902.56M (filed ).
Loading financial statements…
